Zentalis Pharmaceuticals

ZNTL

NASDAQHealth Care

Income Statement

Total Revenue$0

Gross Profit$0

Operating Income$-258.62M

EBITDA$-164.37M

EBIT$-165.66M

Pre-tax Income$-136.62M

Net Income$-165.84M

Cash Equivalent$40.11M

Total Debt$40.99M

Book Value$383.22M

Book Value Per Share5.39

Return on Equity (ROE)-49.18%

Return on Assets (ROA)-38.54%

Return on Invested Capital (ROI)-49.18%

Net Profit Margin-245.96%

Current Ratio7.32

Quick Ratio7.19

Long-Term Debt / Equitynull